IP Library Granted Patent US 10,364,232
Granted Patent B2
US 10,364,232 · App. 15/736,375 · Granted Jul 30, 2019

Antibacterial compounds

Inventors: Jérõme Émile Georges Guillemont (Andé, FR); Magali Madeleine Simone Motte (Louviers, FR); Pierre Jean-Marie Bernard Rabiosson (Rosieres, BE); Abdellah Tahri (Anderlecht, BE)
Assignee: Janssen Sciences Ireland UC
C07D401/12A61K31/404A61K31/429A61K31/437A61K31/438A61K31/444A61K31/4709A61K31/4745A61K31/496A61K31/498A61K31/4985A61K31/519A61K45/06A61P31/04A61P31/06C07D401/14C07D403/12C07D471/04C07D487/04C07D487/10C07D513/04C07D519/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,364,232
App. No.
15/736,375
Granted
Jul 30, 2019
Kind
B2
Abstract

The present invention relates to the following compounds wherein the integers are as defined in the description, and where the compounds may be useful as medicaments, for instance for use in the treatment of tuberculosis.

Claims (15)

1. A compound of formula (I)

wherein

R 1 is CH;

L 1 is —CH 2 —;

X 1 is phenylene;

X a is —CH—

q 1 , q 2 , q 3 and q 4 are each —CH 2 —;

X b is a nitrogen atom;

L 2 is S(O) 2 —C 1-6 alkyl optionally substituted by one or more fluoro atoms;

Ring A and Ring B is:

wherein SUB is halo, C 1-3 alkyl or OC 1-3 alkyl,

or a pharmaceutically acceptable salt thereof.

2. The compound of claim 1 wherein L 2 is —SO 2 CF 3 .

3. The compound of claim 2 that is 6-chloro-2-ethyl-N-({4-[2-(trifluoromethanesulfonyl)-2-azaspiro[3.3]heptan-6-yl]phenyl}methyl)imidazo[1,2-a]pyridine-3-carboxamide.

4. A pharmaceutical composition comprising (i) a therapeutically effective amount of a compound of claim 1 , and (ii) a pharmaceutically acceptable carrier.

Assignments (5)
CHANGE OF NAME Recorded Nov 17, 2021
From: JANSSEN SCIENCES IRELAND UC
To: JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
Reel/Frame 058173/0879 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2019
From: GUILLEMONT, JÉRÔME ÉMILE GEORGES; MOTTE, MAGALI MADELEINE SIMONE
To: JANSSEN-CILAG
Reel/Frame 049381/0435 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2019
From: RABOISSON, PIERRE JEAN-MARIE BERNARD; TAHRI, ABDELLAH
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 049381/0940 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2019
From: JANSSEN-CILAG
To: JANSSEN SCIENCES IRELAND UC
Reel/Frame 049382/0063 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2019
From: JANSSEN PHARMACEUTICA NV
To: JANSSEN SCIENCES IRELAND UC
Reel/Frame 049382/0194 →
Priority Claims (3)
EP 15174936 · Jul 2, 2015 · regional
EP 16174713 · Jun 16, 2016 · regional
EP 16174718 · Jun 16, 2016 · regional
Continuity (1)
Related Publication 20180186768A1 · Jul 5, 2018